A literature review of HRQoL and prevalence of fibrodysplasia ossificans progressiva

Sukannya Mahapatra; Pradeep Manohar Muragundi; Srushti Choughule; Arzoo Piruka

doi:10.7324/JAPS.2023.130303

Abstract

Fibrodysplasia Ossificans Progressiva (FOP) is an ultrarare genetic disorder and a literature review was undertaken to determine the epidemiology of FOP and its impact on the quality of life of patients. Medline® and Embase® databases were searched for Epidemiology and health-related quality of life information using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. English language studies including FOP patients were included. A total of seven studies were identified reporting the epidemiology and eight studies reporting the humanistic burden associated with FOP. The prevalence of FOP ranged from 0.04 to 1.36 per million population. A higher prevalence of FOP was found in the USA (0.88 per million) and Europe (0.47–1.36 per million) compared to the Asian (0.11 per million) population. Patient-Reported Outcomes Measurement Information System (PROMIS) and 36-Item Short Form Health Survey were the most commonly used instruments in FOP to assess the humanistic burden. Assessed on the PROMIS scale moderate to severe pain (≥4, 0–10 pain scale) was commonly associated with flare-ups of FOP (56%–67% of patients experiencing it), and 45%–74% of these patients also experienced anxiety, depression, or irritability. Variability in the prevalence of FOP was reported across geographies. A significant deterioration in the quality of life secondary to progressive deterioration in physical abilities was observed in FOP, therefore, highlighting the need for effective therapies in this highly unmet disease area.

Keyword: FOP quality of life rare disease humanistic burden

Citation:

Mahapatra S, Muragundi PM, Choughule S, Piruka A. A literature review of HRQoL and prevalence of fibrodysplasia ossificans progressive. J Appl Pharm Sci, 2022. https://doi.org/10.7324/JAPS.2023.130303

Copyright: © The Author(s). This is an open-access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reference

Al Mukaddam M, Toder KS, Davis M, Cali A, Liljesthröm M, Hollywood S, Croskery K, Grandoulier AS, Böing EA, Whalen JD, Kaplan FS. The impact of fibrodysplasia ossificans progressiva (FOP) on patients and their family members: results from an international burden of illness survey. Expert Rev Pharmacoecon Outcomes Res, 2022:1-15. https://doi.org/10.2217/frd-2022-0013

Baujat G, Choquet R, Bouée S, Jeanbat V, Courouve L, Ruel A, Michot C, Le Quan Sang KH, Lapidus D, Messiaen C, Landais P, Cormier- Daire V. Prevalence of fibrodysplasia ossificans progressiva (FOP) in France: an estimate based on a record linkage of two national databases. Orphanet J Rare Dis, 2017; 12(1):1-9. https://doi.org/10.1186/s13023-017-0674-5

Cai X, Genchev GZ, He P, Lu H, Yu G. Demographics, in-hospital analysis, and prevalence of 33 rare diseases with effective treatment in Shanghai. Orphanet J Rare diseases, 2021; 16(1):1-1. https://doi.org/10.1186/s13023-021-01830-4

Gupta RR, Delai PL, Glaser DL, Rocke DM, Al Mukaddam M, Pignolo RJ, Kaplan FS. Prevalence and risk factors for kidney stones in fibrodysplasia ossificans progressiva. Bone, 2018; 109:120-3. https://doi.org/10.1016/j.bone.2017.12.010

Kannu P, Levy CE. Improving the diagnosis of fibrodysplasia ossificans progressiva. J Pediatr, 2021; 232:S3-8. https://doi.org/10.1016/j.jpeds.2021.02.036

Kaplan FS, Al Mukaddam M, Pignolo RJ. Longitudinal patient-reported mobility assessment in fibrodysplasia ossificans progressiva (FOP). Bone, 2018; 109:158-61. https://doi.org/10.1016/j.bone.2017.06.005

Kaplan FS, Hsiao EC, Baujat G, Brown MA, De Cunto C, Di Rocco M, Keen R, Al Mukaddam M, Grogan DR, Pignolo RJ. Assessment tools of physical and functional disability in fibrodysplasia ossificans progressiva. J Bone Miner Res, 2017; 32(1):S391.

Kitterman JA, Strober JB, Kan L, Rocke DM, Cali A, Peeper J, Snow J, Delai PL, Morhart R, Pignolo RJ, Shore EM, Kaplan FS. Neurological symptoms in individuals with fibrodysplasia ossificans progressiva. J Neurol, 2012; 259(12):2636-43. https://doi.org/10.1007/s00415-012-6562-y

Kou S, De Cunto C, Baujat G, Wentworth KL, Grogan DR, Brown MA, Di Rocco M, Keen R, Al Mukaddam M, le Quan Sang KH, Masharani U, Kaplan FS, Pignolo RJ, Hsiao EC. Patients with ACVR1 R206H mutations have an increased prevalence of cardiac conduction abnormalities on electrocardiogram in a natural history study of fibrodysplasia ossificans progressiva. Orphanet J Rare Dis, 2020; 15(1):1-0. https://doi.org/10.1186/s13023-020-01465-x

Mantick N, Bachman E, Baujat G, Brown M, Collins O, De Cunto C, Delai P, Eekhoff M, Zum Felde R, Grogan DR, Haga N, Hsiao E, Kantanie S, Kaplan F, Keen R, Milosevic J, Morhart R, Pignolo R, Qian X, di Rocco M, Scott C, Sherman A, Wallace M, Williams N, Zhang K, Bogard B. The FOP connection registry: design of an international patient-sponsored registry for fibrodysplasia ossificans progressiva. Bone, 2018; 109:285-90. https://doi.org/10.1016/j.bone.2017.08.032

Morales-Piga A, Bachiller-Corral J, Trujillo-Tiebas MJ, Villaverde-Hueso A, Gamir-Gamir ML, Alonso-Ferreira V, Vázquez-Díaz M, de la Paz MP, Ayuso-García C. Fibrodysplasia ossificans progressiva in Spain: epidemiological, clinical, and genetic aspects. Bone, 2012; 51(4):748-55. https://doi.org/10.1016/j.bone.2012.07.002

Nakahara Y, Kitoh H, Nakashima Y, Toguchida J, Haga N. Longitudinal study of the activities of daily living and quality of life in Japanese patients with fibrodysplasia ossificans progressiva. Disabil Rehabil, 2019; 41(6):699-704. https://doi.org/10.1080/09638288.2017.1405083

Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V, Murphy D, Le Cam Y, Rath A. Estimating cumulative point prevalence of rare diseases: analysis of the orphanet database. Eur J Hum Genet, 2020; 28(2):165-73. https://doi.org/10.1038/s41431-019-0508-0

Ortiz-Agapito F, Colmenares-Bonilla D. Quality of life of patients with fibrodysplasia ossificans progressiva. J Child Orthop, 2015; 9(6):489-93. https://doi.org/10.1007/s11832-015-0704-6

Peng K, Cheung K, Lee A, Sieberg C, Borsook D, Upadhyay J. Longitudinal evaluation of pain, flare-up, and emotional health in fibrodysplasia ossificans progressiva: analyses of the international FOP registry. JBMR Plus, 2019; 3(8):e10181. https://doi.org/10.1002/jbm4.10181

Peng K, Karunakaran KD, Labadie R, Veliu M, Cheung C, Lee A, Yu PB, Upadhyay J. Suppressed prefrontal cortex oscillations associate with clinical pain in fibrodysplasia ossificans progressiva. Orphanet J Rare Dis, 2021; 16(1):1-3. https://doi.org/10.1186/s13023-021-01709-4

Pignolo RJ, Cheung K, Kile S, Fitzpatrick MA, De Cunto C, Al Mukaddam M, Hsiao EC, Baujat G, Delai P, Eekhoff EM, Di Rocco M, Grunwald Z, Haga N, Keen R, Levi B, Morhart R, Scott C, Sherman A, Zhang K, Kaplan FS. Self-reported baseline phenotypes from the international fibrodysplasia ossificans progressiva (FOP) association global registry. Bone, 2020; 134:115274. https://doi.org/10.1016/j.bone.2020.115274

Pignolo RJ, Hsiao EC, Baujat G, Lapidus D, Sherman A, Kaplan FS. Prevalence of fibrodysplasia ossificans progressiva (FOP) in the United States: estimate from three treatment centers and a patient organization. Orphanet J Rare Dis, 2021; 16(1):1-8. https://doi.org/10.1186/s13023-021-01983-2

She D, Li R, Fang P, Zong G, Xue Y, Zhang K. Serum osteocalcin level is associated with the mortality in Chinese patients with fibrodysplasia ossificans progressiva aged≤ 18 years at diagnosis. BMC Musculoskelet Disord, 2020; 21(1):1-8. https://doi.org/10.1186/s12891-020-3170-3

Zorzi AR, Delai PR, Rosa HL, Brito WE, Montalli VA, Napimoga JC, Napimoga MH, Nociti FH. Fibrodysplasia ossificans progressiva in Brazil: challenges and strategies to create assistance and educational networks. Orphanet J Rare Dis, 2022; 17(1):1-4. https://doi.org/10.1186/s13023-022-02503-6

Abstract

HTML Full Text

Reference

Article Metrics

Related Search

Citiaion Alert By Google Scholar

Similar Articles